Ranbaxy Settles With GSK Over Generic Migraine Drug
Under the settlement, the India-based drugmaker will be able to distribute a generic version of sumatriptan succinate tablets, which are sold under the brand name Imitrex. Ranbaxy says it expects to market the generic migraine medication in December 2008.
GlaxoSmithKline's patent covering Imitrex is set to expire in February 2009.
Ranbaxy will be able to distribute tablets...
To view the full article, register now.